Tangshan People's Hospital   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Tangshan China (1943)

Organization Overview

First Clinical Trial
2015
NCT02621333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Tangshan Maternal and Child Health Hospital | Tangshan People's Hospital

Active Ingredients

Drugs in Phase 3 Trials (2)

docetaxel (taxotere) (1 trial)

nedaplatin (1 trial)

Drugs in Phase 2 Trials (1)

cytokine induced killer cells (1 trial)

Drugs in Other Trials (2)

indocyanine green (ic-green) (1 trial)

methylene blue (proveblue) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Adenocarcinoma of Lung (Phase 2)

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5